Atkinson Sarah H, Armitage Andrew E, Khandwala Shivani, Mwangi Tabitha W, Uyoga Sophie, Bejon Philip A, Williams Thomas N, Prentice Andrew M, Drakesmith Hal
Department of Paediatrics, Oxford University Hospitals, University of Oxford, Oxford, United Kingdom; Oxford University Clinical Academic Graduate School, Oxford, United Kingdom; Kenya Medical Research Institute/Wellcome Trust Research Programme, Centre of Geographic Medicine Research-Coast, Kilifi District Hospital, Kilifi, Kenya;
Medical Research Council Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford University Hospitals, United Kingdom;
Blood. 2014 May 22;123(21):3221-9. doi: 10.1182/blood-2013-10-533000. Epub 2014 Mar 4.
Hepcidin is the master regulatory hormone that governs iron homeostasis and has a role in innate immunity. Although hepcidin has been studied extensively in model systems, there is less information on hepcidin regulation in global health contexts where iron deficiency (ID), anemia, and high infectious burdens (including malaria) all coexist but fluctuate over time. We evaluated iron status, hepcidin levels, and determinants of hepcidin in 2 populations of rural children aged ≤8 years, in the Gambia and Kenya (total n = 848), at the start and end of a malaria season. Regression analyses and structural equation modeling demonstrated, for both populations, similar combinatorial effects of upregulating stimuli (iron stores and to a lesser extent inflammation) and downregulating stimuli (erythropoietic drive) on hepcidin levels. However, malaria season was also a significant factor and was associated with an altered balance of these opposing factors. Consistent with these changes, hepcidin levels were reduced whereas the prevalence of ID was increased at the end of the malaria season. More prevalent ID and lower hepcidin likely reflect an enhanced requirement for iron and an ability to efficiently absorb it at the end of the malaria season. These results, therefore, have implications for ID and malaria control programs.
铁调素是控制铁稳态的主要调节激素,在固有免疫中发挥作用。尽管铁调素已在模型系统中得到广泛研究,但在全球健康背景下,关于铁调素调节的信息较少,在这些背景中,缺铁(ID)、贫血和高感染负担(包括疟疾)同时存在,但会随时间波动。我们在疟疾季节开始和结束时,对冈比亚和肯尼亚两个年龄≤8岁的农村儿童群体(共n = 848)的铁状态、铁调素水平及铁调素的决定因素进行了评估。回归分析和结构方程模型表明,对于这两个群体,上调刺激因素(铁储存以及程度较轻的炎症)和下调刺激因素(红细胞生成驱动力)对铁调素水平具有相似的组合效应。然而,疟疾季节也是一个重要因素,且与这些相反因素的平衡改变有关。与这些变化一致,在疟疾季节结束时,铁调素水平降低,而ID患病率增加。更普遍的ID和更低的铁调素可能反映出在疟疾季节结束时对铁的需求增加以及有效吸收铁的能力。因此,这些结果对ID和疟疾控制项目具有启示意义。